GUGGENHEIM CAPITAL LLC - AVIRAGEN THERAPEUTICS INC ownership

AVIRAGEN THERAPEUTICS INC's ticker is AVIR and the CUSIP is 053761102. A total of 34 filers reported holding AVIRAGEN THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of AVIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$10,000
-28.6%
17,968
-11.1%
0.00%
Q3 2017$14,0000.0%20,212
+0.2%
0.00%
Q2 2017$14,000
+7.7%
20,1750.0%0.00%
Q1 2017$13,000
-45.8%
20,175
+4.2%
0.00%
Q4 2016$24,000
-35.1%
19,3550.0%0.00%
Q3 2016$37,000
+105.6%
19,355
+53.6%
0.00%
Q2 2016$18,00012,6000.00%
Other shareholders
AVIRAGEN THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 1,779,976$3,417,554,0000.88%
Broadfin Capital, LLC 3,486,711$6,694,0000.60%
Stonepine Capital Management, LLC 347,440$667,0000.54%
TOWERVIEW LLC 160,000$307,0000.14%
GABELLI & Co INVESTMENT ADVISERS, INC. 224,477$431,0000.05%
JW Asset Management, LLC 8,611$17,0000.01%
EAGLE GLOBAL ADVISORS LLC 202,922$390,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 204,470$393,0000.01%
Spark Investment Management LLC 41,800$80,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 89,396$172,0000.00%
View complete list of AVIRAGEN THERAPEUTICS INC shareholders